abagovomab 50
abciximab 48
abituzumab 35
abrilumab 33
actoxumab 35
adalimumab 21
aducanumab 19
afasevikumab 22
alacizumab_pegol 15
alemtuzumab 44
alirocumab 26
amatuximab 59
andecaliximab 38
anifrolumab 36
anrukinzumab 22
aprutumab 21
aprutumab_ixadotin 21
arcitumomab 31
ascrinvacumab 27
atezolizumab 16
atinumab 25
avelumab 21
basiliximab 52
bavituximab 54
begelomab 45
benralizumab 42
bevacizumab_beta 26
bezlotoxumab 35
bimagrumab 36
bleselumab 36
blinatumomab 53
blosozumab 41
bococizumab 35
brazikumab 23
brentuximab_vedotin 49
briakinumab 21
brodalumab 35
brolucizumab 31
brontictuzumab 40
burosumab 36
cabiralizumab 41
camrelizumab 16
canakinumab 25
cantuzumab_ravtansin 63
carlumab 35
carotuximab 36
cergutuzumab_amunaleukin2 42
cergutuzumab_amunaleukin 42
certolizumab_pegol 28
cetiximab 55
citatuzumab_bogatox 33
cixutumumab 50
clivatuzumab_tetraxetan 37
codrituzumab 41
conatumumab 28
concizumab 34
crenezumab 24
crizanlizumab 37
crotedumab 28
dacetuzumab 28
daclizumab 32
dalotuzumab 49
dapirolizumab_pegol 30
daratumumab 19
dectrekumab 15
demcizumab 43
denosumab 13
depatuxizumab 38
depatuxizumab_mafodotin 38
dezamizumab 38
dinutuximab 50
diridavumab 40
domagrozumab 20
drozitumab 27
duligotuzumab 21
durvalumab 18
dusigitumab 38
efalizumab 38
efungumab 40
eldelumab 26
elezanumab 41
elgemtumab 15
elotuzumab 25
emactuzumab 37
emapalumab 32
emibetuzumab 33
enavatuzumab 29
enfortumab_vedotin 17
enoblituzumab 23
enokizumab 36
enoticumab 28
ensituximab 50
eptinezumab 23
erenumab 32
etaracizumab 19
etrolizumab 25
evinacumab 26
evolocumab 37
farletuzumab 17
fasinumab 36
fezakinumab 41
fibatuzumab 30
ficlatuzumab 39
firivumab 48
flanvotumab 35
fletikumab 45
foralumab 22
foravirumab 19
fremanezumab 36
fresolimumab 32
fulranumab 23
futuximab 45
galcanezumab 32
ganitumab 43
gantenerumab 21
gemetuzumab 47
gemtuzumab2 42
gemtuzumab 41
gevokizumab 37
girentuximab 41
glembatumumab 40
glembatumumab_vedotin 40
guselkumab 36
ibalizumab 40
ibritumomab 55
icrucumab 22
idarucizumab 52
ifabotuzumab 30
imalumab 20
imgatuzumab 36
inclacumab 27
indatuximab_ravtansin 46
indusatumab 34
inebilizumab 30
intetumumab 21
iodine_girentuximab 34
ipilimumab 14
iratumumab 30
isatuximab 47
itolizumab 32
ixekizumab 46
labetuzumab_govitecan 29
lambrolizumab 41
lampalizumab 34
lanadelumab 21
landogrozumab 22
laprituximab 42
lebrikizumab 49
lendalizumab 39
lenzilumab 34
lifastuzumab_vedotin 28
ligelizumab 36
lilotomab 51
lirilumab 44
lodelcizumab 37
lokivetmab 28
lorvotuzumab_mertansin 29
lucatumumab 35
lumretuzumab 34
lupartumab 20
lutikizumab 24
margetuximab 47
milatuzumab 51
mirvetuximab 50
mirvetuximab_soravtansin 50
modotuximab 61
mogamulizumab 33
monalizumab 38
motavizumab 45
moxetumomab_pasudotox 34
namilumab 41
naratuximab 46
naratuximab_emtansin 46
narnatumab 23
navicixizumab2 39
navicixizumab 44
navivumab 49
necitumumab 29
nemolizumab 42
nesvacumab 21
nivolumab 22
obiltoxaximab 38
obinutuzumab 46
ocaratuzumab 40
ofatumumab 27
olaratumab 38
olokizumab 29
omalizumab 25
onartuzumab 26
ontuxizumab 43
opicinumab 20
orticumab 18
otelixizumab 41
oxelumab 15
ozanezumab 47
pamrevlumab 15
panobacumab 33
parsatuzumab 34
pasotuxizumab 24
pateclizumab 24
patritumab 38
pembrolizumab 41
perakizumab 27
pidilizumab 32
pinatuzumab_vedotin 23
plozalizumab 35
pogalizumab 39
polatuzumab_vedotin 25
ponezumab 52
prezalumab 18
pritoxaximab 60
quilizumab 22
racotumomab 42
radretumab 21
ralpancizumab 37
ramucirumab 18
ranevetmab 35
ranibizumab 29
refanezumab 32
remtolumab 21
rilotumumab 34
rinucumab 36
risankizumab 44
rituximab 43
rivabazumab 29
robatumumab 23
roledumab 36
romosozumab 36
rontalizumab 29
rosmantuzumab 39
rozanolixizumab 27
sacituzumab 41
sacituzumab_govitecan 41
samalizumab 39
sapelizumab 34
sarilumab 20
secukinumab 25
seribantumab 20
setoxaximab 60
sifalimumab 32
siltuximab 37
simtuzumab 43
sirukumab 18
solanezumab 29
solitomab 42
stamulumab 39
suptavumab 34
suvizumab 28
tabalumab 33
tadocizumab 32
tamtuvetmab 40
tanezumab 35
tarextumab 17
tavolixizumab 31
telisotuzumab 45
teplizumab 31
tesidolumab 45
tezepelumab 37
tigatuzumab 20
tildrakizumab 35
timolumab 22
tisotumab 17
tosatoxumab 50
tositumomab 52
tralokinumab 49
trastuzumab 26
tregalizumab 28
trevogrumab 19
ublituximab 48
urelumab 38
ustekinumab 37
utomilumab 42
vadastuximab 41
vadastuximab_talirin 41
vandortuzumab_vedotin 25
vantictumab 30
vanucizumab2 26
vanucizumab 56
varlilumab 20
vatelizumab 39
vedolizumab 43
veltuzumab 37
vesencumab 16
vorsetuzumab 37
vorsetuzumab_mafodotin 37
vunakizumab 46
xentuzumab 23
zatuximab 61
